# FDA Inspection 1279894 - Kite Pharma, Inc. - August 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/6c854143-66e4-4bfa-b0da-a4e4e9b83d60
Source feed: FDA_Inspections

> FDA Inspection 1279894 for Kite Pharma, Inc. on August 27, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1279894
- Company Name: Kite Pharma, Inc.
- Inspection Date: 2025-08-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1155166 - 2021-10-22](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/aef1fdf4-fcc5-44c8-ba94-e905a18663db)
- [FDA Inspection 1155166 - 2021-10-22](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/04652416-8b0d-4877-a0bd-dffeb9a087b1)
- [FDA Inspection 1100058 - 2019-08-20](https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/76901832-4400-44b6-9915-b8aa6c598211)

Company: https://www.keypedia.com/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b